Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes ...

EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work ...

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand ...

Immunotherapy has transformed healthcare and how physicians treat patients. Various forms of immunotherapy have been ...

In this segment, Dr Luskin examines how patient-related factors influence treatment decisions in blastic plasmacytoid ...

The immune system has multiple pathways for recognizing and responding to microbial components and other disease-related stimuli. The dendritic-cell lineage of white blood cells controls this ...

Dendritic cells (DCs) are exceptionally potent antigen-presenting cells (APCs) in the human body and are considered the “sentinels” of the immune system. They are essential in establishing, ...

A variety of DC and macrophage subtypes exist, each with distinct phenotypes and activities, and many can be identified based on panels of cellular markers The manifestation of glomerular or tubular ...

Dendritic cells are divided into Type 1 (DC1) and Type 2 (DC2) dendritic cells. Each type fulfills different functions: DC1 provide an immune response to bacteria and viruses, DC2 protect against ...

Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.